These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 18292383)

  • 1. Spatial distribution of white-matter hyperintensities in Alzheimer disease, cerebral amyloid angiopathy, and healthy aging.
    Holland CM; Smith EE; Csapo I; Gurol ME; Brylka DA; Killiany RJ; Blacker D; Albert MS; Guttmann CR; Greenberg SM
    Stroke; 2008 Apr; 39(4):1127-33. PubMed ID: 18292383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Data-Driven White Matter Hyperintensity Spatial Signatures With Distinct Cerebral Small Vessel Disease Etiologies.
    Phuah CL; Chen Y; Strain JF; Yechoor N; Laurido-Soto OJ; Ances BM; Lee JM;
    Neurology; 2022 Dec; 99(23):e2535-e2547. PubMed ID: 36123127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. White matter hyperintensities and cerebral amyloidosis: necessary and sufficient for clinical expression of Alzheimer disease?
    Provenzano FA; Muraskin J; Tosto G; Narkhede A; Wasserman BT; Griffith EY; Guzman VA; Meier IB; Zimmerman ME; Brickman AM;
    JAMA Neurol; 2013 Apr; 70(4):455-61. PubMed ID: 23420027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extent and distribution of white matter hyperintensities in normal aging, MCI, and AD.
    Yoshita M; Fletcher E; Harvey D; Ortega M; Martinez O; Mungas DM; Reed BR; DeCarli CS
    Neurology; 2006 Dec; 67(12):2192-8. PubMed ID: 17190943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral small vessel disease in aging and Alzheimer's disease: a comparative study using MRI and SPECT.
    Makedonov I; Black SE; MacIntosh BJ
    Eur J Neurol; 2013 Feb; 20(2):243-50. PubMed ID: 22742818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral amyloid angiopathy burden associated with leukoaraiosis: a positron emission tomography/magnetic resonance imaging study.
    Gurol ME; Viswanathan A; Gidicsin C; Hedden T; Martinez-Ramirez S; Dumas A; Vashkevich A; Ayres AM; Auriel E; van Etten E; Becker A; Carmasin J; Schwab K; Rosand J; Johnson KA; Greenberg SM
    Ann Neurol; 2013 Apr; 73(4):529-36. PubMed ID: 23424091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterizing the white matter hyperintensity penumbra with cerebral blood flow measures.
    Promjunyakul N; Lahna D; Kaye JA; Dodge HH; Erten-Lyons D; Rooney WD; Silbert LC
    Neuroimage Clin; 2015; 8():224-9. PubMed ID: 26106546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. White matter hyperintensity patterns: associations with comorbidities, amyloid, and cognition.
    Bachmann D; von Rickenbach B; Buchmann A; Hüllner M; Zuber I; Studer S; Saake A; Rauen K; Gruber E; Nitsch RM; Hock C; Treyer V; Gietl A
    Alzheimers Res Ther; 2024 Apr; 16(1):67. PubMed ID: 38561806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional white matter hyperintensities in normal aging, single domain amnestic mild cognitive impairment, and mild Alzheimer's disease.
    Kim JH; Hwang KJ; Kim JH; Lee YH; Rhee HY; Park KC
    J Clin Neurosci; 2011 Aug; 18(8):1101-6. PubMed ID: 21723730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of white matter hyperintensity measurements on brain MR imaging with cognitive status, medial temporal atrophy, and cardiovascular risk factors.
    Appel J; Potter E; Bhatia N; Shen Q; Zhao W; Greig MT; Raj A; Barker WW; Potter H; Schofield E; Wu Y; Loewenstein DA; Duara R
    AJNR Am J Neuroradiol; 2009 Nov; 30(10):1870-6. PubMed ID: 19643919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. White matter hyperintensities: relationship to amyloid and tau burden.
    Graff-Radford J; Arenaza-Urquijo EM; Knopman DS; Schwarz CG; Brown RD; Rabinstein AA; Gunter JL; Senjem ML; Przybelski SA; Lesnick T; Ward C; Mielke MM; Lowe VJ; Petersen RC; Kremers WK; Kantarci K; Jack CR; Vemuri P
    Brain; 2019 Aug; 142(8):2483-2491. PubMed ID: 31199475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spatial distribution and cognitive impact of cerebrovascular risk-related white matter hyperintensities.
    Veldsman M; Kindalova P; Husain M; Kosmidis I; Nichols TE
    Neuroimage Clin; 2020; 28():102405. PubMed ID: 32971464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis of cerebral microbleeds: In vivo imaging of amyloid and subcortical ischemic small vessel disease in 226 individuals with cognitive impairment.
    Park JH; Seo SW; Kim C; Kim GH; Noh HJ; Kim ST; Kwak KC; Yoon U; Lee JM; Lee JW; Shin JS; Kim CH; Noh Y; Cho H; Kim HJ; Yoon CW; Oh SJ; Kim JS; Choe YS; Lee KH; Lee JH; Ewers M; Weiner MW; Werring DJ; Na DL
    Ann Neurol; 2013 May; 73(5):584-93. PubMed ID: 23495089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI-visible perivascular space location is associated with Alzheimer's disease independently of amyloid burden.
    Banerjee G; Kim HJ; Fox Z; Jäger HR; Wilson D; Charidimou A; Na HK; Na DL; Seo SW; Werring DJ
    Brain; 2017 Apr; 140(4):1107-1116. PubMed ID: 28335021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. White matter hyperintensities in the forties: their prevalence and topography in an epidemiological sample aged 44-48.
    Wen W; Sachdev PS; Li JJ; Chen X; Anstey KJ
    Hum Brain Mapp; 2009 Apr; 30(4):1155-67. PubMed ID: 18465744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma beta-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy.
    Gurol ME; Irizarry MC; Smith EE; Raju S; Diaz-Arrastia R; Bottiglieri T; Rosand J; Growdon JH; Greenberg SM
    Neurology; 2006 Jan; 66(1):23-9. PubMed ID: 16401840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. White matter hyperintensities predict amyloid increase in Alzheimer's disease.
    Grimmer T; Faust M; Auer F; Alexopoulos P; Förstl H; Henriksen G; Perneczky R; Sorg C; Yousefi BH; Drzezga A; Kurz A
    Neurobiol Aging; 2012 Dec; 33(12):2766-73. PubMed ID: 22410648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral microhemorrhage and brain β-amyloid in aging and Alzheimer disease.
    Yates PA; Sirisriro R; Villemagne VL; Farquharson S; Masters CL; Rowe CC;
    Neurology; 2011 Jul; 77(1):48-54. PubMed ID: 21700585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. White matter hyperintensities had a correlation with the cerebral perfusion level, but no correlation with the severity of large vessel stenosis in the anterior circulation.
    Feng F; Kan W; Yang H; Ding H; Wang X; Dong R
    Brain Behav; 2023 Apr; 13(4):e2932. PubMed ID: 36917737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of cerebrospinal fluid profiles in Alzheimer's disease with multiple cerebral microbleeds and cerebral amyloid angiopathy-related inflammation.
    Kimura A; Takemura M; Saito K; Yoshikura N; Hayashi Y; Harada N; Nishida H; Nakajima H; Inuzuka T
    J Neurol; 2017 Feb; 264(2):373-381. PubMed ID: 28000005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.